Farallon Capital Management
Latest statistics and disclosures from Farallon Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are HYG, SPY, MSFT, RSP, AON, and represent 33.58% of Farallon Capital Management's stock portfolio.
- Added to shares of these 10 stocks: HYG (+$1.7B), RSP (+$531M), K (+$324M), LLY (+$286M), ETHA (+$235M), NSC (+$185M), WAB (+$180M), HIMS (+$144M), EXEL (+$143M), AON (+$104M).
- Started 25 new stock positions in ASMB, MLYS, MRUS, ALNY, GDLC, NSC, ETHA, DOCS, ICLR, ABVX.
- Reduced shares in these 10 stocks: SPY (-$1.4B), , IQV (-$553M), LBRDK (-$421M), , VRNA (-$171M), AZEK (-$171M), LNTH (-$166M), GOOG (-$156M), ARMK (-$150M).
- Sold out of its positions in ABT, AKRO, AMED, ANSS, AZEK, BYND, BDSX, BRKR, CHX, YMM.
- Farallon Capital Management was a net seller of stock by $-226M.
- Farallon Capital Management has $24B in assets under management (AUM), dropping by 3.24%.
- Central Index Key (CIK): 0000909661
Tip: Access up to 7 years of quarterly data
Positions held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 144 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Iboxx Hi Yd Etf Put Option (HYG) | 13.0 | $3.2B | +116% | 39M | 81.19 |
|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 9.3 | $2.3B | -38% | 3.4M | 666.18 |
|
| Microsoft Corporation (MSFT) | 4.1 | $991M | +9% | 1.9M | 517.95 |
|
| Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP) | 4.0 | $968M | +121% | 5.1M | 189.70 |
|
| Aon Shs Cl A (AON) | 3.3 | $812M | +14% | 2.3M | 356.58 |
|
| Exelixis (EXEL) | 3.3 | $805M | +21% | 20M | 41.30 |
|
| Amazon (AMZN) | 3.2 | $770M | +15% | 3.5M | 219.57 |
|
| Natera (NTRA) | 2.8 | $685M | -11% | 4.3M | 160.97 |
|
| Revolution Medicines (RVMD) | 2.8 | $683M | +2% | 15M | 46.70 |
|
| UnitedHealth (UNH) | 2.7 | $651M | +16% | 1.9M | 345.30 |
|
| Thermo Fisher Scientific (TMO) | 2.5 | $610M | -9% | 1.3M | 485.02 |
|
| Hims & Hers Health Com Cl A (HIMS) | 2.5 | $610M | +30% | 11M | 56.72 |
|
| Walt Disney Company (DIS) | 2.4 | $595M | +6% | 5.2M | 114.50 |
|
| salesforce (CRM) | 2.4 | $584M | +16% | 2.5M | 237.00 |
|
| Autodesk (ADSK) | 2.2 | $528M | -4% | 1.7M | 317.67 |
|
| Boston Scientific Corporation (BSX) | 1.9 | $463M | +19% | 4.7M | 97.63 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 1.9 | $455M | 7.0M | 65.00 |
|
|
| Wabtec Corporation (WAB) | 1.8 | $442M | +68% | 2.2M | 200.47 |
|
| Bridgebio Pharma (BBIO) | 1.7 | $426M | +3% | 8.2M | 51.94 |
|
| Protagonist Therapeutics (PTGX) | 1.7 | $412M | 6.2M | 66.43 |
|
|
| Transunion (TRU) | 1.6 | $397M | -12% | 4.7M | 83.78 |
|
| Aramark Hldgs (ARMK) | 1.4 | $346M | -30% | 9.0M | 38.40 |
|
| Intuit (INTU) | 1.4 | $333M | -9% | 488k | 682.91 |
|
| Kellogg Company (K) | 1.3 | $324M | NEW | 3.9M | 82.02 |
|
| Nasdaq Omx (NDAQ) | 1.3 | $321M | -11% | 3.6M | 88.45 |
|
| Analog Devices (ADI) | 1.3 | $319M | +2% | 1.3M | 245.70 |
|
| Charles Schwab Corporation (SCHW) | 1.3 | $310M | -17% | 3.3M | 95.47 |
|
| New York Times Cl A (NYT) | 1.2 | $286M | -11% | 5.0M | 57.40 |
|
| Eli Lilly & Co. Put Option (LLY) | 1.2 | $286M | NEW | 375k | 763.00 |
|
| Alphabet Cap Stk Cl C (GOOG) | 1.1 | $273M | -36% | 1.1M | 243.55 |
|
| Cbre Group Cl A (CBRE) | 1.0 | $255M | -23% | 1.6M | 157.56 |
|
| McKesson Corporation (MCK) | 1.0 | $253M | +3% | 327k | 772.54 |
|
| Beam Therapeutics (BEAM) | 1.0 | $244M | 10M | 24.27 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $240M | +24% | 5.8M | 41.65 |
|
| Ishares Ethereum Tr SHS (ETHA) | 1.0 | $235M | NEW | 7.5M | 31.51 |
|
| Agios Pharmaceuticals (AGIO) | 0.9 | $232M | 5.8M | 40.14 |
|
|
| Visa Com Cl A (V) | 0.8 | $205M | +94% | 600k | 341.38 |
|
| Liquidia Corporation Com New (LQDA) | 0.8 | $195M | +102% | 8.6M | 22.74 |
|
| Norfolk Southern (NSC) | 0.8 | $185M | NEW | 615k | 300.41 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.7 | $178M | -48% | 3.5M | 51.29 |
|
| Iqvia Holdings (IQV) | 0.7 | $178M | -75% | 939k | 189.94 |
|
| Woodward Governor Company (WWD) | 0.6 | $157M | -32% | 622k | 252.71 |
|
| Mastercard Incorporated Cl A (MA) | 0.5 | $122M | +40% | 214k | 568.81 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $105M | -4% | 4.3M | 24.25 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.4 | $101M | NEW | 5.0M | 20.20 |
|
| Tango Therapeutics (TNGX) | 0.4 | $90M | +17% | 11M | 8.40 |
|
| Beta Bionics (BBNX) | 0.4 | $86M | +2% | 4.3M | 19.87 |
|
| Tenet Healthcare Corp Com New (THC) | 0.3 | $84M | -21% | 414k | 203.04 |
|
| Grail (GRAL) | 0.3 | $80M | +168% | 1.3M | 59.13 |
|
| Encompass Health Corp (EHC) | 0.3 | $73M | -19% | 571k | 127.02 |
|
| Oscar Health Cl A (OSCR) | 0.3 | $69M | +146% | 3.6M | 18.93 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.3 | $68M | NEW | 805k | 84.90 |
|
| Marathon Digital Holdings In (MARA) | 0.3 | $67M | +338% | 3.7M | 18.26 |
|
| Mineralys Therapeutics (MLYS) | 0.3 | $63M | NEW | 1.7M | 37.92 |
|
| Vnet Group Sponsored Ads A (VNET) | 0.2 | $57M | +83% | 5.5M | 10.33 |
|
| Cidara Therapeutics Com New (CDTX) | 0.2 | $49M | +154% | 508k | 95.76 |
|
| Grayscale Coindesk Crypto Usd Shs (GDLC) | 0.2 | $48M | NEW | 851k | 55.90 |
|
| Mr Cooper Group | 0.2 | $47M | +81% | 222k | 210.79 |
|
| Alnylam Pharmaceuticals Put Option (ALNY) | 0.2 | $46M | NEW | 100k | 456.00 |
|
| Nektar Therapeutics Com New (NKTR) | 0.2 | $45M | NEW | 791k | 56.90 |
|
| Cardinal Health (CAH) | 0.2 | $40M | -44% | 253k | 156.96 |
|
| Joyy Ads Repstg Com A (JOYY) | 0.1 | $37M | -20% | 625k | 58.61 |
|
| Flutter Entmt SHS (FLUT) | 0.1 | $35M | -24% | 137k | 254.00 |
|
| Uniqure Nv SHS (QURE) | 0.1 | $33M | +3935% | 565k | 58.37 |
|
| Assembly Biosciences Com New (ASMB) | 0.1 | $31M | NEW | 1.2M | 25.60 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 0.1 | $30M | -51% | 565k | 53.07 |
|
| Waystar Holding Corp (WAY) | 0.1 | $28M | +22% | 750k | 37.92 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.1 | $27M | NEW | 208k | 131.77 |
|
| Doximity Cl A (DOCS) | 0.1 | $27M | NEW | 374k | 73.15 |
|
| Prime Medicine (PRME) | 0.1 | $26M | +533% | 4.8M | 5.54 |
|
| Enanta Pharmaceuticals (ENTA) | 0.1 | $25M | 2.1M | 11.97 |
|
|
| Surgery Partners (SGRY) | 0.1 | $19M | -54% | 872k | 21.64 |
|
| Tyra Biosciences (TYRA) | 0.1 | $16M | 1.1M | 13.99 |
|
|
| Intellia Therapeutics (NTLA) | 0.0 | $11M | NEW | 607k | 17.27 |
|
| Soleno Therapeutics (SLNO) | 0.0 | $10M | +2960% | 153k | 67.60 |
|
| Tectonic Therapeutic (TECX) | 0.0 | $10M | -24% | 640k | 15.69 |
|
| Savara (SVRA) | 0.0 | $8.9M | -63% | 2.5M | 3.57 |
|
| Novavax Com New (NVAX) | 0.0 | $6.8M | +4775% | 780k | 8.67 |
|
| Schrodinger (SDGR) | 0.0 | $5.7M | -74% | 284k | 20.06 |
|
| Ishares Tr Ishares Semicdtr (SOXX) | 0.0 | $5.1M | NEW | 19k | 271.12 |
|
| Allete Com New (ALE) | 0.0 | $5.0M | NEW | 75k | 66.40 |
|
| Tvardi Therapeutics (TVRD) | 0.0 | $1.7M | 43k | 38.97 |
|
|
| Alvotech Ordinary Shares (ALVO) | 0.0 | $1.6M | 200k | 8.19 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $1.5M | 3.3k | 458.66 |
|
|
| Summit Midstream Corporation (SMC) | 0.0 | $1.2M | 58k | 20.54 |
|
|
| Brightspring Health Svcs (BTSG) | 0.0 | $650k | 22k | 29.56 |
|
|
| Alkermes SHS (ALKS) | 0.0 | $624k | -96% | 21k | 30.00 |
|
| Roivant Sciences SHS (ROIV) | 0.0 | $560k | 37k | 15.13 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $545k | 16k | 34.49 |
|
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $539k | -98% | 5.0k | 107.74 |
|
| Guardant Health (GH) | 0.0 | $500k | 8.0k | 62.48 |
|
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $490k | 26k | 18.85 |
|
|
| Axsome Therapeutics (AXSM) | 0.0 | $486k | 4.0k | 121.45 |
|
|
| Healthequity (HQY) | 0.0 | $474k | -98% | 5.0k | 94.77 |
|
| Insmed Com Par $.01 (INSM) | 0.0 | $432k | 3.0k | 144.01 |
|
|
| Progyny (PGNY) | 0.0 | $387k | 18k | 21.52 |
|
|
| Beone Medicines Sponsored Ads (ONC) | 0.0 | $375k | 1.1k | 340.70 |
|
|
| Krystal Biotech (KRYS) | 0.0 | $353k | 2.0k | 176.53 |
|
|
| Arcellx Common Stock (ACLX) | 0.0 | $328k | 4.0k | 82.10 |
|
|
| Cg Oncology (CGON) | 0.0 | $322k | 8.0k | 40.28 |
|
|
| Livanova SHS (LIVN) | 0.0 | $314k | 6.0k | 52.38 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $314k | NEW | 4.8k | 65.42 |
|
| AmerisourceBergen (COR) | 0.0 | $313k | 1.0k | 312.53 |
|
|
| Capricor Therapeutics Com New (CAPR) | 0.0 | $296k | 41k | 7.21 |
|
|
| Travere Therapeutics (TVTX) | 0.0 | $287k | 12k | 23.90 |
|
|
| Merus N V (MRUS) | 0.0 | $283k | NEW | 3.0k | 94.15 |
|
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.0 | $279k | 28k | 9.96 |
|
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.0 | $278k | 1.4k | 198.81 |
|
|
| Sabra Health Care REIT (SBRA) | 0.0 | $261k | 14k | 18.64 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 0.0 | $261k | 7.0k | 37.24 |
|
|
| Nuvalent Inc-a (NUVL) | 0.0 | $259k | -98% | 3.0k | 86.48 |
|
| Merit Medical Systems (MMSI) | 0.0 | $250k | 3.0k | 83.23 |
|
|
| Cogent Biosciences (COGT) | 0.0 | $244k | 17k | 14.36 |
|
|
| Veracyte (VCYT) | 0.0 | $240k | NEW | 7.0k | 34.33 |
|
| Globus Med Cl A (GMED) | 0.0 | $229k | -98% | 4.0k | 57.27 |
|
| Aleanna *w Exp 12/13/202 (ANNAW) | 0.0 | $226k | 990k | 0.23 |
|
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.0 | $225k | -99% | 3.0k | 75.10 |
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $220k | NEW | 3.0k | 73.31 |
|
| Urogen Pharma (URGN) | 0.0 | $220k | NEW | 11k | 19.95 |
|
| Healthcare Rlty Tr Cl A Com (HR) | 0.0 | $216k | 12k | 18.03 |
|
|
| Twist Bioscience Corp (TWST) | 0.0 | $215k | 7.7k | 28.14 |
|
|
| Glaukos (GKOS) | 0.0 | $212k | 2.6k | 81.55 |
|
|
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $211k | -99% | 7.0k | 30.08 |
|
| Icon SHS (ICLR) | 0.0 | $210k | NEW | 1.2k | 175.00 |
|
| Immunovant (IMVT) | 0.0 | $193k | 12k | 16.12 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $182k | NEW | 24k | 7.59 |
|
| Pacific Biosciences of California (PACB) | 0.0 | $173k | 135k | 1.28 |
|
|
| Solid Power *w Exp 12/08/202 (SLDPW) | 0.0 | $168k | 405k | 0.42 |
|
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $154k | 10k | 15.38 |
|
|
| Blue Gold *w Exp 04/01/203 (BGLWW) | 0.0 | $137k | NEW | 300k | 0.46 |
|
| Ardelyx (ARDX) | 0.0 | $127k | 23k | 5.51 |
|
|
| Dyne Therapeutics (DYN) | 0.0 | $127k | 10k | 12.65 |
|
|
| Amicus Therapeutics (FOLD) | 0.0 | $126k | 16k | 7.88 |
|
|
| Evolent Health Cl A (EVH) | 0.0 | $118k | 14k | 8.46 |
|
|
| Altimmune Com New (ALT) | 0.0 | $104k | 28k | 3.77 |
|
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $62k | 28k | 2.22 |
|
|
| Aleanna Com Cl A (ANNA) | 0.0 | $62k | 78k | 0.79 |
|
|
| Geron Corporation (GERN) | 0.0 | $59k | 43k | 1.37 |
|
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $56k | 26k | 2.17 |
|
|
| Canopy Growth Corp Com New (CGC) | 0.0 | $44k | 30k | 1.46 |
|
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $36k | 120k | 0.30 |
|
|
| Beyond Meat | 0.0 | $36k | NEW | 19k | 1.89 |
|
| Nvni Group *w Exp 11/01/202 (NVNIW) | 0.0 | $27k | 375k | 0.07 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $17k | 13k | 1.31 |
|
Past Filings by Farallon Capital Management
SEC 13F filings are viewable for Farallon Capital Management going back to 2010
- Farallon Capital Management 2023 Q3 amended filed Nov. 14, 2025
- Farallon Capital Management 2023 Q4 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q1 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q2 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q3 amended filed Nov. 14, 2025
- Farallon Capital Management 2024 Q4 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q1 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q2 amended filed Nov. 14, 2025
- Farallon Capital Management 2025 Q3 filed Nov. 14, 2025
- Farallon Capital Management 2024 Q3 amended filed Aug. 14, 2025
- Farallon Capital Management 2024 Q1 amended filed Aug. 14, 2025
- Farallon Capital Management 2024 Q2 amended filed Aug. 14, 2025
- Farallon Capital Management 2024 Q4 amended filed Aug. 14, 2025
- Farallon Capital Management 2025 Q1 amended filed Aug. 14, 2025
- Farallon Capital Management 2025 Q2 filed Aug. 14, 2025
- Farallon Capital Management 2023 Q4 amended filed Aug. 14, 2025